TLPH FY 2018 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2M-73.1% YoY

Gross Profit

-$2M-84.8% margin

Operating Income

-$36M-1660.9% margin

Net Income

-$47M-2192.0% margin

EPS (Diluted)

$-16.14

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$30M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$121M

Total Liabilities

$116M

Stockholders' Equity

$4M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$8M	-73.1%
Gross Profit	-$2M	-$3M	+31.5%
Operating Income	-$36M	-$39M	+7.6%
Net Income	-$47M	-$52M	+8.5%